Lewes, DE -- (SBWire) -- 10/01/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: LIGHTSTREAM RES(OTCMKTS:LSTMF), American Graphite Technologies Inc(OTCBB:AGIN),Global National Communications Corp.(OTCMKTS:GNCP), Invivo Therapeutics Holdings Corp(OTCBB:NVIV).
LIGHTSTREAM RES(OTCMKTS:LSTMF) ended lower -0.72% and complete the day at $6.93. The total number of shares changed hands during the day was 86,258. After opening at $6.96, the stock hit as high as $6.99. However, it traded between $6.71 and $8.65 over the last twelve months.
Lightstream Resources Ltd. operates as an oil and gas exploration and production company focusing on light oil Bakken and Cardium resource plays with conventional light oil assets in Canada.
Has LSTMF Found The Bottom and Ready To Move Up? Find out via this report
American Graphite Technologies Inc(OTCBB:AGIN) closed yesterday at $0.156. Around 1.24 million shares were traded, beating an-average trading volume of 355,914 shares. The company is now valued at around $12.20 million.
American Graphite Technologies Inc., an exploration stage company, focuses on the acquisition, exploration, and development of graphite related mineral properties primarily in the United States.
Is AGIN a Solid Investment at These Levels? Find out via this report
Global National Communications Corp.(OTCMKTS:GNCP) moved +58.33 percent higher at $0.0019 and traded between $0.0014 and $0.0026 after opening the day at $0.0015. Its performance over the last five days remained 111.11%, which stands at -5% for a month. Going back further than one month, 1-year performance after recent close was -86.71%.
GNCC Capital, Inc., an exploration stage company, engages in the acquisition, exploration, and development of gold and silver properties in North America. It has three gold and three silver exploration projects located in Arizona.
Will GNCP Continue To Move Higher? Find Out Here
Invivo Therapeutics Holdings Corp(OTCBB:NVIV) trade close at $1.58. The stock is down around -9.2% this year and 1.94% for the last 12 months. Around 386,891 shares changed hands yesterday, lower from an-average trading volume of 1.25 million shares.
Invivo Therapeutics Holdings Corp., a development stage company, focuses on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries, peripheral nerve injuries, and other neurotrauma conditions
What NVIV Charts Are Signaling for Traders? Find Out Here
About LeadingStockAlerts:
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
Disclaimer:
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/
Penny Stocks Intraday Alert - LIGHTSTREAM RES(OTCMKTS:LSTMF), American Graphite Technologies Inc(OTCBB:AGIN),Global National Communications Corp.(OTCMKTS:GNCP), Invivo Therapeutics Holdings Corp(OTCBB:NVIV)